Longitudinal Autonomic Characterization as a Predictor for Secondary Medical Complications Post-SCI
Mayo Clinic
18 participants
Jan 31, 2026
INTERVENTIONAL
Conditions
Summary
The purpose of this research is to learn about how the body is able to balance changes in blood pressure, how that changes over time, and how these changes impact a participant's risk of developing medical problems.
Eligibility
Inclusion Criteria4
- -75 years old
- Spinal cord injury with neurological level of injury from C6-T12
- ASIA Impairment Scale A-D.
- Either acute SCI <3 months prior (n=10) or chronic SCI (>1 year since injury, n=8).
Exclusion Criteria4
- Symptoms of cardiovascular (including, but not limited to: hypertension, stroke, chest pain, etc.), respiratory, peripheral neurological or autonomic disease (particularly diabetes mellitus requiring treatment);
- Women who are pregnant or lactating
- Taking or being administered a medication known to potentially have adverse interactions with phenylephrine
- In the judgement of the principal investigator, any illness or condition that will interfere with the patient's ability to comply with the protocol, compromise patient safety, or interfere with the interpretation of the study results.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Bolus phenylephrine infusion using the Oxford technique will generate the need to inhibit sympathetic activity. Similarly, resting state Mayer waves will be assessed with regard to heart rate and blood pressure responses.
Cold pressor test of the hand will be used to cause sympathetic activation. Valsalva's maneuver will assess the ability to buffer against blood pressure fall (phase II).
Cold pressor test of the foot and bladder pressor response will be tested.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07210437